High Tide Reports Approximately $2 Million in Retail Sales on ‘4/20’
April 23, 2024
NUROSENE LAUNCHES NETRAPLACEBO, AN INNOVATIVE AI TECHNOLOGY TO IMPACT CLINICAL TRIAL SUCCESS RATES IN THE US$94B CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTICS MARKET.(1)
February 17, 2022
Related Post
-
-
DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
April 9, 2024
-
Cloud DX Announces Proposed $2.8 Million Private Placement
April 8, 2024
-
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
April 4, 2024